快樂小藥師
- Apr 22 Fri 2011 05:38
[PDR Drug Alert]Serious Risks of QT prolongation, Torsades de pointes and Sudden death for vandetanib; FDA required restricted distribution program.
- Apr 21 Thu 2011 07:30
[Medscape]Short-Acting Imiquimod Cream Approved for Genital Warts
The US Food and Drug Administration (FDA) has approved the use of 3.75% imiquimod cream (Zyclara Cream) for the treatment of external anogenital warts in people aged 12 years and older, according to an announcement released by Graceway Pharmaceuticals, which manufactures the cream.
- Apr 20 Wed 2011 06:57
[MEDLINE Abstract]Cinacalcet in the treatment of persistent hyperparathyroidism after kidney transplantation
Clin Nephrol. 2011; 75(3):263-8 (ISSN: 0301-0430)
- Apr 19 Tue 2011 05:58
[Medscape][AccessMedicine from McGraw-Hill]Acute Blood Pressure Lowering in Stroke Is Ineffective and Possibly Harmful
S. Andrew Josephson, MD
- Apr 18 Mon 2011 05:21
[US pharmacist]An Overview of Kawasaki Disease 綜觀川崎氏症
Sarah Dodds, PharmD Candidate
Texas Southern University COPHS
Linda Nguyen, PharmD Candidate
University of Houston College of Pharmacy
Erika Jackson Bergeron, PharmD
Clinical Pharmacist II
Harris County Hospital District
Houston, Texas
- Apr 17 Sun 2011 06:12
fundamental of Ashtanga
Ashtanga,Sri K. Pattabhi Jois創立的瑜伽教派,Pattabhi大師是Iyengar大師的師兄弟。Ashtanga的特色是強力連續的體位法操練,強調動作與呼吸的配合,以 及採用Ujjayi呼吸法,Ashtanga Yoga依照困難度安排數套連續不斷的體位法順序,每套完全練完要一到二小時甚至更久,其中包含許多困難的動作,Ashatanga Yoga會讓練習者對自己的身體產生強烈的信心。
- Apr 16 Sat 2011 07:59
甲癬 Onychomycosis,tinea unguium
- Apr 15 Fri 2011 05:11
[Medscape Medical News]Morphine/Naltrexone Combo Temporarily Withdrawn
King Pharmaceuticals Inc, a wholly owned subsidiary of Pfizer, has voluntarily recalled all dosages of a combination morphine sulfate and naltrexone hydrochloride (Embeda Extended Release Capsules CII) from wholesalers and retailers in the United States because "a prespecified stability requirement was not met during routine testing," a message on the product's Website notes.
- Apr 14 Thu 2011 05:31
[Medscape][CME]Emerging Therapies in Multiple Sclerosis
Multiple sclerosis (MS) is a chronic disease of the central nervous system (CNS) with presumed inflammatory and degenerative elements. MS entered the rather small ranks of neurologic diseases with disease-modifying therapies in 1993. Since then, 6 agents have received regulatory approval. Five of these agents are indicated for treatment of the relapsing forms of MS and 1 agent for more severe, worsening forms. No therapy is approved or has shown efficacy in treating primary progressive MS. All of the currently available agents are immunomodulatory, strongly supporting the evidence that the pathogenesis of MS relates to an immune aberration. MS has much in common with autoimmune diseases of other organs; although there are abundant data supporting a dysimmune state in patients with MS, the proof of autoimmunity is not yet available. The successful employment of immunomodulating therapies also raises questions about the potential role of other putative causes for MS. Although it had been hoped that increased knowledge of the immunopathogenesis of MS would lead to more focused therapies, that goal has only been partially realized.
- Apr 13 Wed 2011 07:25
[US pharmacist]Hypertensive Crises: Urgencies and Emergencies 高血壓危象
Yolanda M. Hardy, PharmD
Assistant Professor of Pharmacy Practice
Chicago State University College of Pharmacy
Chicago, Illinois
Antoine T. Jenkins, PharmD, BCPS
Assistant Professor of Pharmacy Practice
Chicago State University College of Pharmacy
Chicago, Illinois
- Apr 11 Mon 2011 05:18
[Medscape]Why Do Antihypertensives Cause Cough? 為何將血壓藥物會引起咳嗽?
Question
What are the mechanisms of cough caused by angiotensin-converting enzyme inhibitors, beta-blockers, and calcium channel blockers, and how can this adverse effect be managed?
- Apr 10 Sun 2011 05:25
[FDA Medwatch]Benzocaine Topical Products: Sprays, Gels and Liquids - Risk of Methemoglobinemia(變性血紅素血症)
- Apr 09 Sat 2011 06:26
哪些癌症可以用標把藥物治療?
哪些癌症可以用標把藥物治療
- Apr 08 Fri 2011 06:07
2011第一季新藥記錄
Ocrelizumab:RA用藥
- Apr 07 Thu 2011 05:27
圖解藥理學-21 抗真菌藥的機轉 03
- Apr 06 Wed 2011 05:30
圖解藥理學-13 化療藥機轉 11
修正細胞訊號學的部分,所以再次改版
- Apr 05 Tue 2011 06:01
Technique - Partial or Full Nail Removal 全甲拔除或部分指甲移除
- Apr 03 Sun 2011 05:34
[好站推薦]text to mind map
就像你到的圖片一樣,這東西叫做心智圖
- Apr 02 Sat 2011 05:29
足癬 Tinea Pedis
- Apr 01 Fri 2011 05:31
藥師在災區可以做什麼?
以史為鏡,可以之興替,歷史最重要的功能,就是讓後人避免重蹈覆轍。(雖然人類有不斷重複做相同錯事的喜好)
這次日本發生如此大災難,你當然可以相信媒體轉述的「台灣不可能」,但也可以居安思危,想一下,今天把你放到相同的場景,你可以做什麼?
- Mar 31 Thu 2011 05:59
FDA Drug Safety Communication: Special storage and handling requirements must be followed for Pradaxa (dabigatran etexilate mesylate) capsules
The U.S. Food and Drug Administration (FDA) is alerting the public to important storage and handling requirements for Pradaxa (dabigatran etexilate mesylate) capsules. Due to the potential for product breakdown from moisture and loss of potency, Pradaxa capsules should only be dispensed and stored in the original bottle or blister package and patients should be aware of the specific handling requirements.